BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21539537)

  • 1. Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
    Ng AK
    Br J Haematol; 2011 Jul; 154(1):23-31. PubMed ID: 21539537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late complications of therapy of Hodgkin's disease: prevention and management.
    Ng AK; Mauch PM
    Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of treatment-related cardiac toxicity on lymphoma survivors: an institutional approach for risk reduction and management.
    Walsh MC
    Clin J Oncol Nurs; 2010 Aug; 14(4):505-7. PubMed ID: 20682507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late effects of Hodgkin's disease and its treatment.
    Ng AK; Mauch PM
    Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High risk of symptomatic cardiac events in childhood cancer survivors.
    van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
    J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease.
    van Leeuwen-Segarceanu EM; Bos WJ; Dorresteijn LD; Rensing BJ; der Heyden JA; Vogels OJ; Biesma DH
    Cancer Treat Rev; 2011 Aug; 37(5):391-403. PubMed ID: 21333452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac pathology in patients after therapy for Hodgkin's lymphoma].
    Danilenko AA; Shakhtarina SV
    Vopr Onkol; 2011; 57(1):119-25. PubMed ID: 21598720
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
    van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset cardiotoxicity of chemotherapy and radiotherapy.
    Dietz B; van der Hem KG
    Neth J Med; 2003 Jun; 61(6):228-31. PubMed ID: 12948167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term complications of lymphoma and its treatment.
    Ng AK; LaCasce A; Travis LB
    J Clin Oncol; 2011 May; 29(14):1885-92. PubMed ID: 21483015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
    De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
    J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Late complications after treatment of Hodgkin's disease].
    Lund MB; Kongerud J; Boe J; Ihlen H; Forfang K; Abrahamsen AF; Nome O
    Tidsskr Nor Laegeforen; 1999 Mar; 119(7):933-7. PubMed ID: 10210953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac toxicity of mediastinal radiotherapy: which are the critical structures?
    Vordermark D; Seufert I; Schwab F; Flentje M; Kung M; Angermann C
    J Clin Oncol; 2005 May; 23(15):3634-6; author reply 3636. PubMed ID: 15908679
    [No Abstract]   [Full Text] [Related]  

  • 14. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.
    Schellong G; Riepenhausen M; Bruch C; Kotthoff S; Vogt J; Bölling T; Dieckmann K; Pötter R; Heinecke A; Brämswig J; Dörffel W
    Pediatr Blood Cancer; 2010 Dec; 55(6):1145-52. PubMed ID: 20734400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second cancers in survivors of hodgkin lymphoma: risks and recommendations.
    Leahy Y
    Clin J Oncol Nurs; 2008 Jun; 12(3):437-42. PubMed ID: 18515242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac toxicity in cancer therapy].
    Łacko A; Włodarska I; Zymliński R; Mazur G; Wróbel T; Gisterek I
    Pol Merkur Lekarski; 2002 Jul; 13(73):79-85. PubMed ID: 12362515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
    Hodgson DC; Hudson MM; Constine LS
    Semin Radiat Oncol; 2007 Jul; 17(3):230-42. PubMed ID: 17591570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma.
    Oguz A; Tayfun T; Citak EC; Karadeniz C; Tatlicioglu T; Boyunaga O; Bora H
    Pediatr Blood Cancer; 2007 Oct; 49(5):699-703. PubMed ID: 17420991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
    Shankar SM; Marina N; Hudson MM; Hodgson DC; Adams MJ; Landier W; Bhatia S; Meeske K; Chen MH; Kinahan KE; Steinberger J; Rosenthal D;
    Pediatrics; 2008 Feb; 121(2):e387-96. PubMed ID: 18187811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cardiovascular evaluation of patients with Hodgkin's disease treated by thoracic mantle radiation therapy.
    Applefeld MM; Slawson RG; Spicer KM; Singleton RT; Wesley MN; Wiernik PH
    Cancer Treat Rep; 1982 Apr; 66(4):1003-13. PubMed ID: 7074628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.